MOCERTATUG
UNII 4JGB654X2S

Substance Identification & Data

This profile provides standardized clinical and technical data for Mocertatug, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4JGB654X2S.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3042847-92-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

4JGB654X2S

CAS Registry Number

3042847-92-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

MOCERTATUG

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C223292

National Cancer Institute reference terminology for clinical and research data.

INN ID

13781

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Mocertatug. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

MOCERTATUG

Common Names & Synonyms

H-GAMMA1 HEAVY CHAIN HUMANIZED (1-450) (VH (HOMO SAPIENS IGHV3-23*04 (87.8%) -(IGHD) -IGHJ4*01 (93.3%) L123>T (115), CDR-IMGT (8.8.13) (26-33.51-58.97-109)) (1-120) -HOMO SAPIENS IGHG1*03V (100%) G1M3>G1M17, NG1M1 CH1 K120, CH3 E12, M14 (CH1 R120>K (217) (121-218), HINGE 1-15 (219-233), CH2 (234-343), CH3 E12 (359), M14 (361) (344-448), CHS (449-450)) (121-450)), (223-214')-DISULFIDE WITH L-KAPPA LIGHT CHAIN HUMANIZED (1'-214') (V-KAPPA (HOMO SAPIENS IGKV3-11*01 (87.6%) -IGKJ2*01 (100%), CDR-IMGT (6.3.9) (27'-32'.50'-52'.89'-97')) (1'-107') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1, V101 (C-KAPPA A45.1 (153'), V101 (191')) (108'-214')); DIMER (229-229'':232-232'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1, GLYCOFORM ALFA

IMMUNOGLOBULIN G1, ANTI-(HUMAN-MUS MUSCULUS B7 HOMOLOG PROTEIN B7H4) (HUMAN MONOCLONAL GSK5730912 .GAMMA.-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL GSK5730912 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS VTCN1 (V-SET DOMAIN CONTAINING T CELL ACTIVATION INHIBITOR 1, B7 FAMILY MEMBER H4, B7H4, B7-H4)), HUMANIZED MONOCLONAL ANTIBODY (MOCERTATUG)

MOCERTATUG [INN]

External Clinical & Regulatory Resources

Previous UNII4JG7O04XYX

Next UNII4JGJ9O7P4J